1. S. F. Semenov and N. N. Popova, Neuromental Disorders in the Light of Immunopathology of the Brain, Meditsina, Moscow (1969).
2. A. O. Shpakov, “Peptide derivatives of the extracellular loop of receptors: structure, mechanism of action, and use in physiology and medicine,” Ros. Fiziol. Zh., 97, No. 5, 441–458 (2011).
3. F. Andrade, L. A. Casciola-Rosen, and A. Rosen, “Granzyme B-induced cell death,” Acta Haematol., 111, No. 1–2, 28–41 (2004).
4. S. Araga, R. D. LeBoeuf, and J. E. Blalock, “Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor,” Proc. Natl. Acad. Sci. USA, 90, No. 18, 8747–8751 (1993).
5. Y. Arinuma, T. Yanagida, and S. Hirohata, “Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus,” Am. Rheum. Assoc., 58, No. 4, 1130–1135 (2008).